A Patient-Level Meta-Analysis of FOLFIRINOX for Locally Advanced Pancreatic Cancer

HPB - United Kingdom
doi 10.1016/j.hpb.2016.02.888
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Resectability After Neoadjuvant FOLFIRINOX in Locally Advanced Pancreatic Cancer: A Single-Center Experience

HPB
HepatologyGastroenterology
2016English

Final Analysis of a Phase II Study of Modified FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2016English

The Benefits of Modified FOLFIRINOX for Advanced Pancreatic Cancer and Its Induced Adverse Events: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2018English

Outcomes With FOLFIRINOX for Borderline Resectable and Locally Unresectable Pancreatic Cancer

Journal of Surgical Oncology
MedicineSurgeryOncology
2013English

Systematic Review of FOLFIRINOX in Patients With Locally Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis

International Journal of Cancer
Cancer ResearchOncology
2018English

Radiofrequency Ablation for Unresectable Locally Advanced Pancreatic Cancer: A Systematic Review

HPB
HepatologyGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy